6.5.2 Oral semaglutide in established T2D (mean disease duration: 79 years) In patients with T2D uncontrolled on metformin (PIONEER 2), oral semaglutide (14 mg) provided significantly greater reductions in HbA 1c versus empagliflozin (25 mg) at Week 26 (1.3% vs 0.9%
Other Weight-Loss Medications Adding weight-loss drugs like phentermine to semaglutide medication may seem attractive but carries significant risks
Most clinics will schedule regular check-ins to record weight, measure BMI, and discuss changes in appetite or eating habits
One example is orforglipron , an oral GLP-1 for the treatment of type 2 diabetes and obesity
Cancer Care www.cancercare.org 800-813-4673 275 Seventh Avenue (Between West 25 th & 26 th Streets) New York, NY 10001 Provides counseling, support groups, educational workshops, publications, and financial assistance
Because they work differently, they also have distinct side effect profiles and suitability criteria, which are worth understanding before choosing a treatment
